SCHEMBL18325645

SCHEMBL18325645

CCc1ccc2c(C)cc(NC(C)=O)nc2c1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 2/20 0.45
RAB9A P51151 2/20 0.45
POLB P06746 1/20 0.45
CASP3 P42574 1/20 0.45
SENP8 Q96LD8 1/20 0.45
SENP7 Q9BQF6 1/20 0.45
SENP6 Q9GZR1 1/20 0.45
KDM4E B2RXH2 4/20 0.43
MEN1 O00255 2/20 0.41
KMT2A Q03164 2/20 0.41
ELANE P08246 2/20 0.40
ALDH1A1 P00352 1/20 0.40
HPGD P15428 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
NUDT1 P36639 1/20 0.39
HSP90AA1 P07900 1/20 0.39
HSP90AB1 P08238 1/20 0.39
NOS3 P29474 1/20 0.39
NOS1 P29475 1/20 0.39
ADORA3 P0DMS8 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18317027 0.89 MEN1 (0.41) KDM4EMEN1KMT2AALDH1A1HPGD
SCHEMBL18317035 0.88 MEN1 (0.41) KDM4EMEN1KMT2AALDH1A1HPGD
SCHEMBL18317003 0.88 MEN1 (0.43) NPC1KDM4EMEN1KMT2AALDH1A1
SCHEMBL18317017 0.80 NOS3 (0.46) NPC1RAB9AKDM4EMEN1KMT2A
SCHEMBL17646472 0.80 F2 (0.53) NPC1RAB9AKDM4EALDH1A1NUDT1
SCHEMBL17646471 0.79 KDM4E (0.41) KDM4ENUDT1HSP90AA1HSP90AB1ADORA3
SCHEMBL16984472 0.78 KDM4E (0.55) RAB9APOLBKDM4EMEN1KMT2A
SCHEMBL18327761 0.77 GLS (0.38) NPC1RAB9APOLBCASP3SENP8
SCHEMBL9724344 0.77 MAPT (0.45) NPC1POLBKDM4EMEN1KMT2A
Acetic Acid SCHEMBL9849558 0.77 KDM4E (0.54) RAB9APOLBKDM4EMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9783500-B2 2-aminoquinoline-based compounds for potent and selective neuronal nitric oxide synthase inhibition NORTHWESTERN UNIVERSITY (US) 2017-10-10 US disclosed
US-20160368877-A1 2-Aminoquinoline-Based Compounds for Potent and Selective Neuronal Nitric Oxide Synthase Inhibition NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2016-12-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160368877-A1 2-Aminoquinoline-Based Compounds for Potent and Selective Neuronal Nitric Oxide Synthase Inhibition NOS2, NOS3, NOS1 NPC1 1883/4885RAB9A 2178/4885POLB 2405/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.